OR WAIT null SECS
June 06, 2016
An article in Nature Reviews Drug Delivery reports the clinical success rates of biologics, and these numbers differ from those recently highlighted in a similar BIO study.
June 02, 2016
New pharmacovigilance activities seek to support the creation of guidelines for safe switching from innovator products to biosimilars.
As the battle for ownership over the use of CRISPR to edit DNA heats up, some of the CRISPR pioneers refocus their efforts to demonstrate the technology’s applications for editing RNA.
May 31, 2016
Lagarde will be based out of the company’s Boston office and will lead Patheon’s global corporate and cross-enterprise operations.
May 25, 2016
In the largest-ever report of its kind, drugs entering clinical development in Phase I were found to have only a 1 in 10 chance of FDA approval.
Colorcon Acquired BASF’s Kollicoat IR Coating System product line, which includes currently customer business, and inventory.
May 24, 2016
FDA accepted for review Samsung Bioepis’ BLA for SB2, a biosimilar to Remicade (infliximab).
May 18, 2016
The NIH and partners will launch a large-scale clinical trial in South Africa to evaluate the effectiveness of an HIV vaccine regimen
May 16, 2016
Pfizer will acquire Anacor for $5.2 billion and expects the transaction to complete in the third-quarter of 2016.
May 12, 2016
The updated guidelines detail best practices for conducting research with human embryonic stem cells.